GammaRips

CMPX

BULL
2026-02-27

Overnight Institutional Flow Signal

See the 2026-02-27 Morning Briefing

This is one candidate from GammaRips' nightly scan of 5,000+ tickers, curated into a small high-signal pool and tracked to its outcome — data, not a recommendation. New here? See how the pool is built → Or put your AI agent on this data →

Score
8/10
Move
3.6%
Flow
$3.6M
Engine Flags(1/5 patterns matched — diagnostic, not a trade signal)
📈
Strong Call FlowAggressive bullish accumulation
AI Trade Thesis
CMPX BULL $7.50C Apr 17. William Blair initiation and Q4 corporate update provide a strong fundamental floor ahead of high-impact COMPANION-002 survival data due in late March. Entry near $6.00 with a $10.00 price target as the market prices in a high probability of a successful BLA filing. Risk: Potential clinical data delay or broader biotech sector volatility.
Flow Breakdown
Call Volume
$3.5M
Put Volume
$48K
Flow Intent
DIRECTIONAL
Catalyst
Analyst Upgrade
More Bullish Flow · 2026-02-27
Engine-Selected Contract
ContractO:CMPX260320C00006000
Strike$6.00
Expiration2026-03-20
Contract Score7.575/10
Risk/Reward0.1:1
Delta0.68
Key Levels
Resistance$5.80
Support$5.60
Price$5.78
SMA 50 / 200$6 / $4
52W Range$1$7
RSI (14)42
News & Catalyst Analysis

Key Headline

William Blair Initiates Compass Therapeutics (CMPX) with Outperform Rating, Citing Blockbuster Potential for Tovecimig

News Summary

Compass Therapeutics is rising on the back of a high-conviction 'Outperform' initiation from William Blair, which values the lead asset tovecimig as a potential $1.46 billion blockbuster. This bullish sentiment is further bolstered by the company's Q4 earnings window and confirmed cash runway into 2028, keeping the focus on upcoming pivotal data readouts.

Flow Intent Analysis

The $3.5M bullish flow is disproportionate to the modest 3.6% price move and appears to be front-running the pivotal late-Q1 Phase 2/3 survival data readout for tovecimig.

One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.

Free weekly newsletter. No spam. Unsubscribe anytime.

Read the 2026-02-27 morning briefing for the full scan this CMPX signal came from: the bull and bear split, the themes institutional money leaned into, and every other ticker that cleared the bar that day.

How We Read This Flow

Plain-English explainers on the methodology behind signals like this one.

View all →

One email a week. Catch up in five minutes.

The GammaRips weekly briefing — engine state, the latest Lab experiment, and what the pool's outcome data showed. No firehose, no FOMO.

Free weekly newsletter. No spam. Unsubscribe anytime.

    We Use Cookies

    We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.